These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28887220)

  • 21. Antitumor activity of ZD6474, a vascular endothelial growth factor-2 and epidermal growth factor receptor small molecule tyrosine kinase inhibitor, in combination with SC-236, a cyclooxygenase-2 inhibitor.
    Tuccillo C; Romano M; Troiani T; Martinelli E; Morgillo F; De Vita F; Bianco R; Fontanini G; Bianco RA; Tortora G; Ciardiello F
    Clin Cancer Res; 2005 Feb; 11(3):1268-76. PubMed ID: 15709198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cooperative antitumor effect of multitargeted kinase inhibitor ZD6474 and ionizing radiation in glioblastoma.
    Damiano V; Melisi D; Bianco C; Raben D; Caputo R; Fontanini G; Bianco R; Ryan A; Bianco AR; De Placido S; Ciardiello F; Tortora G
    Clin Cancer Res; 2005 Aug; 11(15):5639-44. PubMed ID: 16061883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-tumour efficacy on glioma models of PHA-848125, a multi-kinase inhibitor able to cross the blood-brain barrier.
    Albanese C; Alzani R; Amboldi N; Degrassi A; Festuccia C; Fiorentini F; Gravina G; Mercurio C; Pastori W; Brasca M; Pesenti E; Galvani A; Ciomei M
    Br J Pharmacol; 2013 May; 169(1):156-66. PubMed ID: 23347136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
    Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q
    J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aggregable Nanoparticles-Enabled Chemotherapy and Autophagy Inhibition Combined with Anti-PD-L1 Antibody for Improved Glioma Treatment.
    Ruan S; Xie R; Qin L; Yu M; Xiao W; Hu C; Yu W; Qian Z; Ouyang L; He Q; Gao H
    Nano Lett; 2019 Nov; 19(11):8318-8332. PubMed ID: 31610656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma.
    Li M; Shi K; Tang X; Wei J; Cun X; Chen X; Yu Q; Zhang Z; He Q
    Eur J Pharm Sci; 2018 Nov; 124():240-248. PubMed ID: 30071282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Muscone/RI7217 co-modified upward messenger DTX liposomes enhanced permeability of blood-brain barrier and targeting glioma.
    Kang S; Duan W; Zhang S; Chen D; Feng J; Qi N
    Theranostics; 2020; 10(10):4308-4322. PubMed ID: 32292496
    [No Abstract]   [Full Text] [Related]  

  • 28. Targeted therapy against EGFR and VEGFR using ZD6474 enhances the therapeutic potential of UV-B phototherapy in breast cancer cells.
    Sarkar S; Rajput S; Tripathi AK; Mandal M
    Mol Cancer; 2013 Oct; 12(1):122. PubMed ID: 24138843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GX15-070 (Obatoclax), a Bcl-2 family proteins inhibitor engenders apoptosis and pro-survival autophagy and increases Chemosensitivity in neuroblastoma.
    Cournoyer S; Addioui A; Belounis A; Beaunoyer M; Nyalendo C; Le Gall R; Teira P; Haddad E; Vassal G; Sartelet H
    BMC Cancer; 2019 Oct; 19(1):1018. PubMed ID: 31664947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor vascular strategy for controlling experimental metastatic spread of human small-cell lung cancer cells with ZD6474 in natural killer cell-depleted severe combined immunodeficient mice.
    Yano S; Muguruma H; Matsumori Y; Goto H; Nakataki E; Edakuni N; Tomimoto H; Kakiuchi S; Yamamoto A; Uehara H; Ryan A; Sone S
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8789-98. PubMed ID: 16361567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potent antitumor effects of ZD6474 on neuroblastoma via dual targeting of tumor cells and tumor endothelium.
    Beaudry P; Nilsson M; Rioth M; Prox D; Poon D; Xu L; Zweidler-Mckay P; Ryan A; Folkman J; Ryeom S; Heymach J
    Mol Cancer Ther; 2008 Feb; 7(2):418-24. PubMed ID: 18245671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-permeable NF-κB inhibitor-conjugated liposomes for treatment of glioma.
    Zhang Y; Zhang L; Hu Y; Jiang K; Li Z; Lin YZ; Wei G; Lu W
    J Control Release; 2018 Nov; 289():102-113. PubMed ID: 30243823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of autophagy is an early response to gefitinib and a potential therapeutic target in breast cancer.
    Dragowska WH; Weppler SA; Wang JC; Wong LY; Kapanen AI; Rawji JS; Warburton C; Qadir MA; Donohue E; Roberge M; Gorski SM; Gelmon KA; Bally MB
    PLoS One; 2013; 8(10):e76503. PubMed ID: 24146879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic Combination of Doxorubicin and Paclitaxel Delivered by Blood Brain Barrier and Glioma Cells Dual Targeting Liposomes for Chemotherapy of Brain Glioma.
    Chen X; Yuan M; Zhang Q; Ting Yang Y; Gao H; He Q
    Curr Pharm Biotechnol; 2016; 17(7):636-50. PubMed ID: 27033513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ZD6474, a new treatment strategy for human osteosarcoma, and its potential synergistic effect with celecoxib.
    Liu J; Wu J; Zhou L; Pan C; Zhou Y; Du W; Chen JM; Zhu X; Shen J; Chen S; Liu RY; Huang W
    Oncotarget; 2015 Aug; 6(25):21341-52. PubMed ID: 26050198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting.
    Liu Y; Ran R; Chen J; Kuang Q; Tang J; Mei L; Zhang Q; Gao H; Zhang Z; He Q
    Biomaterials; 2014 Jun; 35(17):4835-47. PubMed ID: 24651033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor effects of ZD6474 on head and neck squamous cell carcinoma.
    Sano D; Kawakami M; Fujita K; Kimura M; Yamashita Y; Ishiguro Y; Nishimura G; Matsuda H; Tsukuda M
    Oncol Rep; 2007 Feb; 17(2):289-95. PubMed ID: 17203163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biotin and glucose co-modified multi-targeting liposomes for efficient delivery of chemotherapeutics for the treatment of glioma.
    Liu Q; Zhou L; Lu R; Yang C; Wang S; Hai L; Wu Y
    Bioorg Med Chem; 2021 Jan; 29():115852. PubMed ID: 33189509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triple branched RGD modification on liposomes: A prospective strategy to enhance the glioma targeting efficiency.
    Li Z; Lu J; Tang B; Shi Y; Hai L; Guo L; Wu Y
    Bioorg Med Chem; 2022 Apr; 60():116704. PubMed ID: 35286953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue distribution and metabolism of the tyrosine kinase inhibitor ZD6474 (Zactima) in tumor-bearing nude mice following oral dosing.
    Gustafson DL; Bradshaw-Pierce EL; Merz AL; Zirrolli JA
    J Pharmacol Exp Ther; 2006 Aug; 318(2):872-80. PubMed ID: 16644900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.